Effects of hospice-shared care on terminal cancer patients in Taiwan: A hospital-based observational study
To assess how hospice-shared care (HSC) affected the likelihood of aggressive medical treatments and the life quality among terminal cancer patients. In the first part, a cohort of 160 late-stage cancer patients who died in non-hospice wards were identified to review their charts in their last 22 da...
Gespeichert in:
| Veröffentlicht in: | European journal of oncology nursing : the official journal of European Oncology Nursing Society 2024-04, Vol.69, p.102525-102525, Article 102525 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 102525 |
|---|---|
| container_issue | |
| container_start_page | 102525 |
| container_title | European journal of oncology nursing : the official journal of European Oncology Nursing Society |
| container_volume | 69 |
| creator | Huang, Hui-Wen Liu, Chun-Yu Tung, Tao-Hsin Liu, Li-Ni |
| description | To assess how hospice-shared care (HSC) affected the likelihood of aggressive medical treatments and the life quality among terminal cancer patients.
In the first part, a cohort of 160 late-stage cancer patients who died in non-hospice wards were identified to review their charts in their last 22 days before death. In the second part, a total of 19 late-stage cancer patients with clear consciousness admitted to non-hospice wards were identified to investigate their quality of life for the final 2 weeks before death.
The utilization rate of HSC was 55.6%. Among these, the rate for late referral to HSC (≤7 days before death) was 43.8% and early referral (>3 months before death) was 5.6%. Compared to the non-HSC group, in the last few weeks of life, the HSC group underwent lower incidence of chemotherapy use (10.1% vs. 39.4%, p |
| doi_str_mv | 10.1016/j.ejon.2024.102525 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2925033798</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1462388924000231</els_id><sourcerecordid>2925033798</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-3ffaceb2ff5f2cd5dd085d24c11b6514da1cceaf0caa2d349ef74bc7b6b3f9093</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMoVqsv4EJm6WZqbnMTN6XUCxTc1HXIJCc0w3RSk2mlb2-GqS7d5ITD__1wPoTuCJ4RTPLHZgaN62YUUx4XNKPZGboiGaMpJZSexz_PacrKspqg6xAajHHFivISTVjJOM45v0LN0hhQfUicSTYu7KyCNGykB52o-CauS3rwW9vJNi46BT7Zyd5CFxHbJWtpv2X3lMxHuJdtWssQYVcH8IeYdAMZ-r0-3qALI9sAt6c5RZ8vy_XiLV19vL4v5qtUMVz0KTNGKqipMZmhSmda4zLTlCtC6jwjXEuiFEiDlZRUM16BKXitijqvmanihVP0MPbuvPvaQ-jF1gYFbSs7cPsgaEUzzFhRlTFKx6jyLgQPRuy83Up_FASLwbFoxOBYDI7F6DhC96f-fb0F_Yf8So2B5zEA8cqDBS-CisYUaOuja6Gd_a__Bxrij7Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2925033798</pqid></control><display><type>article</type><title>Effects of hospice-shared care on terminal cancer patients in Taiwan: A hospital-based observational study</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Huang, Hui-Wen ; Liu, Chun-Yu ; Tung, Tao-Hsin ; Liu, Li-Ni</creator><creatorcontrib>Huang, Hui-Wen ; Liu, Chun-Yu ; Tung, Tao-Hsin ; Liu, Li-Ni</creatorcontrib><description>To assess how hospice-shared care (HSC) affected the likelihood of aggressive medical treatments and the life quality among terminal cancer patients.
In the first part, a cohort of 160 late-stage cancer patients who died in non-hospice wards were identified to review their charts in their last 22 days before death. In the second part, a total of 19 late-stage cancer patients with clear consciousness admitted to non-hospice wards were identified to investigate their quality of life for the final 2 weeks before death.
The utilization rate of HSC was 55.6%. Among these, the rate for late referral to HSC (≤7 days before death) was 43.8% and early referral (>3 months before death) was 5.6%. Compared to the non-HSC group, in the last few weeks of life, the HSC group underwent lower incidence of chemotherapy use (10.1% vs. 39.4%, p < .001), signed do-not-resuscitate orders (0% vs. 21.1%, p < .001), emergency room visits (13.5% vs. 40.8%, p < .001), intensive care unit admission or ventilator use (2.2% vs. 11.3%, p = .019), and endotracheal intubation (2.2% vs. 9.9%, p = .038). However, the quality of life did not appear to have obvious differences between the two groups (p > .05).
In Taiwan, late HSC referral in terminal cancer patients is common. HSC is associated with a reduced likelihood of aggressive medical utilization. However, the effect of HSC in improving patients’ quality of life in the last few weeks needs to be further evaluated.
•Hospice care has been shown to relieve suffering and improve the quality of life of terminal cancer patients.•As cancer treatments advance, integrating hospice care into standard medical care for terminal patients becomes crucial.•In Taiwan, late hospice-shared care referral in terminal cancer patients is common.•Hospice-shared care reduces aggressive cancer treatments and unnecessary life-sustaining measures in patients' final weeks.•Hospice-shared care does not appear to positively impact end-of-life quality in the final two weeks for patients.</description><identifier>ISSN: 1462-3889</identifier><identifier>EISSN: 1532-2122</identifier><identifier>DOI: 10.1016/j.ejon.2024.102525</identifier><identifier>PMID: 38340644</identifier><language>eng</language><publisher>Scotland: Elsevier Ltd</publisher><subject>Anti-Cancer treatment ; Hospice-shared care ; Intensive medical utilization ; Late referral ; Quality of life</subject><ispartof>European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2024-04, Vol.69, p.102525-102525, Article 102525</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-3ffaceb2ff5f2cd5dd085d24c11b6514da1cceaf0caa2d349ef74bc7b6b3f9093</cites><orcidid>0000-0002-9632-5373</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejon.2024.102525$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38340644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Hui-Wen</creatorcontrib><creatorcontrib>Liu, Chun-Yu</creatorcontrib><creatorcontrib>Tung, Tao-Hsin</creatorcontrib><creatorcontrib>Liu, Li-Ni</creatorcontrib><title>Effects of hospice-shared care on terminal cancer patients in Taiwan: A hospital-based observational study</title><title>European journal of oncology nursing : the official journal of European Oncology Nursing Society</title><addtitle>Eur J Oncol Nurs</addtitle><description>To assess how hospice-shared care (HSC) affected the likelihood of aggressive medical treatments and the life quality among terminal cancer patients.
In the first part, a cohort of 160 late-stage cancer patients who died in non-hospice wards were identified to review their charts in their last 22 days before death. In the second part, a total of 19 late-stage cancer patients with clear consciousness admitted to non-hospice wards were identified to investigate their quality of life for the final 2 weeks before death.
The utilization rate of HSC was 55.6%. Among these, the rate for late referral to HSC (≤7 days before death) was 43.8% and early referral (>3 months before death) was 5.6%. Compared to the non-HSC group, in the last few weeks of life, the HSC group underwent lower incidence of chemotherapy use (10.1% vs. 39.4%, p < .001), signed do-not-resuscitate orders (0% vs. 21.1%, p < .001), emergency room visits (13.5% vs. 40.8%, p < .001), intensive care unit admission or ventilator use (2.2% vs. 11.3%, p = .019), and endotracheal intubation (2.2% vs. 9.9%, p = .038). However, the quality of life did not appear to have obvious differences between the two groups (p > .05).
In Taiwan, late HSC referral in terminal cancer patients is common. HSC is associated with a reduced likelihood of aggressive medical utilization. However, the effect of HSC in improving patients’ quality of life in the last few weeks needs to be further evaluated.
•Hospice care has been shown to relieve suffering and improve the quality of life of terminal cancer patients.•As cancer treatments advance, integrating hospice care into standard medical care for terminal patients becomes crucial.•In Taiwan, late hospice-shared care referral in terminal cancer patients is common.•Hospice-shared care reduces aggressive cancer treatments and unnecessary life-sustaining measures in patients' final weeks.•Hospice-shared care does not appear to positively impact end-of-life quality in the final two weeks for patients.</description><subject>Anti-Cancer treatment</subject><subject>Hospice-shared care</subject><subject>Intensive medical utilization</subject><subject>Late referral</subject><subject>Quality of life</subject><issn>1462-3889</issn><issn>1532-2122</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKAzEUhoMoVqsv4EJm6WZqbnMTN6XUCxTc1HXIJCc0w3RSk2mlb2-GqS7d5ITD__1wPoTuCJ4RTPLHZgaN62YUUx4XNKPZGboiGaMpJZSexz_PacrKspqg6xAajHHFivISTVjJOM45v0LN0hhQfUicSTYu7KyCNGykB52o-CauS3rwW9vJNi46BT7Zyd5CFxHbJWtpv2X3lMxHuJdtWssQYVcH8IeYdAMZ-r0-3qALI9sAt6c5RZ8vy_XiLV19vL4v5qtUMVz0KTNGKqipMZmhSmda4zLTlCtC6jwjXEuiFEiDlZRUM16BKXitijqvmanihVP0MPbuvPvaQ-jF1gYFbSs7cPsgaEUzzFhRlTFKx6jyLgQPRuy83Up_FASLwbFoxOBYDI7F6DhC96f-fb0F_Yf8So2B5zEA8cqDBS-CisYUaOuja6Gd_a__Bxrij7Y</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Huang, Hui-Wen</creator><creator>Liu, Chun-Yu</creator><creator>Tung, Tao-Hsin</creator><creator>Liu, Li-Ni</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9632-5373</orcidid></search><sort><creationdate>20240401</creationdate><title>Effects of hospice-shared care on terminal cancer patients in Taiwan: A hospital-based observational study</title><author>Huang, Hui-Wen ; Liu, Chun-Yu ; Tung, Tao-Hsin ; Liu, Li-Ni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-3ffaceb2ff5f2cd5dd085d24c11b6514da1cceaf0caa2d349ef74bc7b6b3f9093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-Cancer treatment</topic><topic>Hospice-shared care</topic><topic>Intensive medical utilization</topic><topic>Late referral</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Hui-Wen</creatorcontrib><creatorcontrib>Liu, Chun-Yu</creatorcontrib><creatorcontrib>Tung, Tao-Hsin</creatorcontrib><creatorcontrib>Liu, Li-Ni</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of oncology nursing : the official journal of European Oncology Nursing Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Hui-Wen</au><au>Liu, Chun-Yu</au><au>Tung, Tao-Hsin</au><au>Liu, Li-Ni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of hospice-shared care on terminal cancer patients in Taiwan: A hospital-based observational study</atitle><jtitle>European journal of oncology nursing : the official journal of European Oncology Nursing Society</jtitle><addtitle>Eur J Oncol Nurs</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>69</volume><spage>102525</spage><epage>102525</epage><pages>102525-102525</pages><artnum>102525</artnum><issn>1462-3889</issn><eissn>1532-2122</eissn><abstract>To assess how hospice-shared care (HSC) affected the likelihood of aggressive medical treatments and the life quality among terminal cancer patients.
In the first part, a cohort of 160 late-stage cancer patients who died in non-hospice wards were identified to review their charts in their last 22 days before death. In the second part, a total of 19 late-stage cancer patients with clear consciousness admitted to non-hospice wards were identified to investigate their quality of life for the final 2 weeks before death.
The utilization rate of HSC was 55.6%. Among these, the rate for late referral to HSC (≤7 days before death) was 43.8% and early referral (>3 months before death) was 5.6%. Compared to the non-HSC group, in the last few weeks of life, the HSC group underwent lower incidence of chemotherapy use (10.1% vs. 39.4%, p < .001), signed do-not-resuscitate orders (0% vs. 21.1%, p < .001), emergency room visits (13.5% vs. 40.8%, p < .001), intensive care unit admission or ventilator use (2.2% vs. 11.3%, p = .019), and endotracheal intubation (2.2% vs. 9.9%, p = .038). However, the quality of life did not appear to have obvious differences between the two groups (p > .05).
In Taiwan, late HSC referral in terminal cancer patients is common. HSC is associated with a reduced likelihood of aggressive medical utilization. However, the effect of HSC in improving patients’ quality of life in the last few weeks needs to be further evaluated.
•Hospice care has been shown to relieve suffering and improve the quality of life of terminal cancer patients.•As cancer treatments advance, integrating hospice care into standard medical care for terminal patients becomes crucial.•In Taiwan, late hospice-shared care referral in terminal cancer patients is common.•Hospice-shared care reduces aggressive cancer treatments and unnecessary life-sustaining measures in patients' final weeks.•Hospice-shared care does not appear to positively impact end-of-life quality in the final two weeks for patients.</abstract><cop>Scotland</cop><pub>Elsevier Ltd</pub><pmid>38340644</pmid><doi>10.1016/j.ejon.2024.102525</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9632-5373</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1462-3889 |
| ispartof | European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2024-04, Vol.69, p.102525-102525, Article 102525 |
| issn | 1462-3889 1532-2122 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2925033798 |
| source | ScienceDirect Journals (5 years ago - present) |
| subjects | Anti-Cancer treatment Hospice-shared care Intensive medical utilization Late referral Quality of life |
| title | Effects of hospice-shared care on terminal cancer patients in Taiwan: A hospital-based observational study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A41%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20hospice-shared%20care%20on%20terminal%20cancer%20patients%20in%20Taiwan:%20A%20hospital-based%20observational%20study&rft.jtitle=European%20journal%20of%20oncology%20nursing%20:%20the%20official%20journal%20of%20European%20Oncology%20Nursing%20Society&rft.au=Huang,%20Hui-Wen&rft.date=2024-04-01&rft.volume=69&rft.spage=102525&rft.epage=102525&rft.pages=102525-102525&rft.artnum=102525&rft.issn=1462-3889&rft.eissn=1532-2122&rft_id=info:doi/10.1016/j.ejon.2024.102525&rft_dat=%3Cproquest_cross%3E2925033798%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2925033798&rft_id=info:pmid/38340644&rft_els_id=S1462388924000231&rfr_iscdi=true |